Parallel Advisors’s Immunogen Inc IMGN Stock Holding History

Parallel Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-876	Closed	-$26K	–	3457
2023 Q4	$26K	Buy	876 +848	+3,029%	+$16.9K	﹤0.01%	1778
2023 Q3	$444	Hold	28	–	–	﹤0.01%	3127
2023 Q2	$528	Sell	28 -70	-71%	-$826	﹤0.01%	3090
2023 Q1	$376	Buy	+98	New	+$418	﹤0.01%	3188
2022 Q1	–	Sell	-37	Closed	–	–	3363
2021 Q4	$0	Buy	+37	New	+$230	﹤0.01%	3360
2019 Q1	–	Sell	-502	Closed	-$2K	–	2426
2018 Q4	$2K	Hold	502	–	–	﹤0.01%	1933
2018 Q3	$5K	Hold	502	–	–	﹤0.01%	1757
2018 Q2	$4K	Buy	+502	New	+$5.29K	﹤0.01%	1701

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Parallel Advisors's IMGN Position: Q1 2024 in Review

Parallel Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 876 shares — an estimated $26K sold.

Parallel Advisors first reported a position in IMGN in Q2 2018 and held it in 8 quarters. The position peaked at $26K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Parallel Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Parallel Advisors sold 876 Immunogen Inc shares in Q1 2024, an estimated $26K.
Parallel Advisors first reported a position in Immunogen Inc in Q2 2018 and held it in 8 quarters.
Parallel Advisors's Immunogen Inc position peaked at $26K in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Parallel Advisors's 13F filing for Q1 2024, filed 6 May 2024.